ADC Therapeutics SA (ADCT) Misses Q4 EPS by 44c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

Go back to ADC Therapeutics SA (ADCT) Misses Q4 EPS by 44c

ADC Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Business Updates

March 18, 2021 7:00 AM EDT

- Lonca BLA accepted by FDA with priority review; PDUFA date May 21, 2021

- Commercial, medical affairs, CMC and support functions prepared for potential Lonca approval

- Updated data for lead programs Lonca and Cami presented at American Society of Hematology (ASH) Annual Meeting in December 2020

- Overland ADCT BioPharma launched to develop and commercialize select products in greater China and Singapore

- Company to host conference call today at 8:30 a.m. EDT

LAUSANNE, Switzerland--(BUSINESS WIRE)-- ADC Therapeutics SA (NYSE:... More